Elraglusib (9-ING-41) is a glycogen synthase kinase-3 beta (GSK-3β) inhibitor. The ongoing phase 1/2 Actuate-1902 trial ...

The drugmaker’s U.S. plans comes on the heels of a rough quarter, with lower vaccine demand driving down Q3 sales by 15% year ...

The VoxScan app allows users to interact with MRI and CT scans on everyday devices, aiming to improve patient outcomes and ...

Also Read: Just After Pfizer’s RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population Specialty Medicine sales increased ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy. Join our lupus registry, RAY, and ...

Blue Cross Blue Shield is the best health insurance company in North Carolina. Its cheapest plan costs $458 per month before discounts. Blue Cross and Blue Shield of NC: Best overall Blue Cross and ...

When Hurricane Helene damaged western North Carolina in September, filling medical facilities with people who couldn’t be ...

More than a month after Hurricane Helene devastated regions in the southeastern United States, some communities in western North Carolina's mountain towns and villages are still without water ...

Welcome to today's call and webcast. The Q3 presentation was sent to our distribution list by e-mail and you can also find it on gsk.com. Please turn to Slide 2. This is the usual safe harbor ...

GlaxoSmithKline ( (GSK)) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors. GlaxoSmithKline (GSK) is a global biopharmaceutical ...

(Reuters) -GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, ...

In a strategic move to enhance their immunology portfolio, GSK has announced an agreement to acquire experimental therapy CMG1A46 from Chimagen Biosciences, a privately-held biotechnology company ...